181 related articles for article (PubMed ID: 1329942)
1. [Immunohistochemical evidence of vimentin in fibrocystic breast disease and mammary carcinoma].
Alexiev B; Valkov I; Popov A
Zentralbl Pathol; 1992 Sep; 138(4):284-8. PubMed ID: 1329942
[TBL] [Abstract][Full Text] [Related]
2. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
5. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
Andersen J; Nielsen M; Christensen L
Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
[No Abstract] [Full Text] [Related]
6. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
[TBL] [Abstract][Full Text] [Related]
7. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
8. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
Mehtani VG; Joshi K; Mehrotra GC
Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
[No Abstract] [Full Text] [Related]
9. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
10. Laminin production and fibronectin immunoreactivity in breast carcinomas.
Gorczyca W; Holm R; Nesland JM
Anticancer Res; 1993; 13(4):851-8. PubMed ID: 8394677
[TBL] [Abstract][Full Text] [Related]
11. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
Walther B; Rutter G; Stegner HE; Böcker W
Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
[No Abstract] [Full Text] [Related]
12. [Breast cancer].
Van Bogaert LJ
Rev Fr Gynecol Obstet; 1984 May; 79(5):361-98. PubMed ID: 6098952
[No Abstract] [Full Text] [Related]
13. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.
Domagala W; Striker G; Szadowska A; Dukowicz A; Weber K; Osborn M
Am J Pathol; 1992 Nov; 141(5):1003-12. PubMed ID: 1332483
[TBL] [Abstract][Full Text] [Related]
15. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
16. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
Böcker W; Jarasch ED; Nagle EB; Höhne R
Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
[No Abstract] [Full Text] [Related]
17. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950
[TBL] [Abstract][Full Text] [Related]
18. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
19. The significance of intraduct appearances in breast cancer.
Cowen PN; Bates C
Clin Oncol; 1984 Mar; 10(1):67-72. PubMed ID: 6323084
[TBL] [Abstract][Full Text] [Related]
20. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
